Patents Examined by Andrew M. Gilbert
  • Patent number: 10799690
    Abstract: An applicator 270 includes a stem 174 having an axially-formed slot delivery passage 200. A slot 350 is formed transaxially through the stem 174 and is in communication with the slot delivery passage 200. An extended side wall 350b is formed on one side of the slot 350. A flat surface 354, which is formed in the stem 174, is spaced and extends angularly away from an opposite side of the slot 176 and from the extended side wall 350b to provide for direct and lateral dispensing of a cream 280 onto a tissue 242 of a patient.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: October 13, 2020
    Assignee: SYRINGE LLC
    Inventors: Armand Maaskamp, Ryan Maaskamp, Irwin R. Berman, Gervasio Salgado, Richard D. Gillespie, III
  • Patent number: 10729855
    Abstract: A drive mechanism suitable for use in drug delivery devices is disclosed. The drive mechanism may be used with injector-type drug delivery devices, such as those permitting a user to set the delivery dose. The drive mechanism may include a housing, a dose dial sleeve, and a drive sleeve. A clutch is configured to permit rotation of the drive sleeve and the dose dial sleeve with respect to the housing when the dose dial sleeve and drive sleeve are coupled through the clutch. Conversely, when the dose dial sleeve and drive sleeve are in a de-coupled state, rotation of the dose dial sleeve with respect to the housing is permitted and rotation of the drive sleeve with respect to the housing is prevented. In the de-coupled state, axial movement of the drive sleeve transfers force in a longitudinal direction for actuation of a drug delivery device.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: August 4, 2020
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Robert Frederick Veasey, Robert Perkins, David Aubrey Plumptre
  • Patent number: 10639428
    Abstract: The present disclosure is generally directed to a drug delivery device for selecting and dispensing a number of user variable doses of a medicament and to an insert for such a device. The insert comprises a cup-shaped body with a distal end and a proximal end. The body has a sidewall and a tube which extends centrally through the cup-shaped body in a longitudinal direction, thereby defining an annular space between the sidewall and the tube. The annular space is open in the proximal direction for receiving a compression spring. The tube comprises a thread provided at an inner surface of the tube. Further, the tube, the sidewall and/or a second part comprise a clutch feature for rotationally constraining a component part to the insert.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: May 5, 2020
    Assignee: Sanofi
    Inventor: Anthony Paul Morris
  • Patent number: 10624696
    Abstract: Systems, methods and devices for creating an effect using microwave energy to specified tissue are disclosed herein. A system for the application of microwave energy to a tissue can include, in some embodiments, a signal generator adapted to generate a microwave signal having predetermined characteristics, an applicator connected to the generator and adapted to apply microwave energy to tissue, the applicator comprising one or more microwave antennas and a tissue interface, a vacuum source connected to the tissue interface, a cooling source connected to said tissue interface, and a controller adapted to control the signal generator, the vacuum source, and the coolant source. The tissue may include a first layer and a second layer, the second layer below the first layer, and the controller is configured such that the system delivers energy such that a peak power loss density profile is created in the second layer.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: April 21, 2020
    Assignee: MIRADRY, INC.
    Inventors: Mark E. Deem, Daniel Francis, Jessi E. Johnson, Steven Kim, Alexey Salamini, Ted Su, Peter Smith, Dan Hallock
  • Patent number: 10603423
    Abstract: A peritoneal dialysis system includes: a drain container; a drain line placed in fluid communication with the drain container and configured to be placed in fluid communication with a patient's peritoneal cavity; a vacuum source configured to apply a pneumatic force to cause used dialysis fluid to flow through the drain line from the patient's peritoneal cavity to the drain container; a weight sensor configured to output a weight of used dialysis fluid delivered to the drain container from the patient's peritoneal cavity; and a controller configured to: (i) determine an actual flow rate of used dialysis fluid removed from the patient's peritoneal cavity based on the output from the weight sensor; (ii) compare the actual flow rate to a desired flow rate; and (iii) adjust the pneumatic force applied by the vacuum source to attempt to match the actual flow rate to the optimal flow rate.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: March 31, 2020
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventors: Robert W. Childers, Scott Keeling, Li Pan
  • Patent number: 10583259
    Abstract: An injection device includes a housing and a setting part configured to, in relation to said housing, rotate in a first rotational direction when an amount of injection fluid to be dispensed is being set. The setting part rotates in a second rotational direction counter to the first rotational direction when the injection fluid is pressed out of the injection device. A latching unit defines at least one latching position of the setting part and acts between the setting part and the housing. The latching unit is active at least when the amount of injection fluid to be dispensed is set and each of the latching positions has an unequivocal rotational position of the setting part in relation to the housing assigned thereto.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: March 10, 2020
    Assignee: Haselmeier AG
    Inventor: Joachim Keitel
  • Patent number: 10561792
    Abstract: The disclosure is directed to a drug delivery device comprising a housing retaining a primary drug delivery assembly and a secondary drug delivery assembly. The secondary drug delivery assembly comprises a secondary dose setting mechanism with a biasing member adapted to reset the secondary dose setting mechanism in a resetting movement. An actuator is movable relative to the housing and comprises a first engagement section configured to engage a second engagement section provided by an actuation collar such that an actuation movement of the actuator is transferred to the actuation collar. A setting element is movable between a first position and a second position and is connected to the secondary dose setting mechanism such that during the resetting movement of the secondary dose setting mechanism, the setting element is moved from the second position into the first position.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: February 18, 2020
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Marc Holtwick, Wolfgang Marx, Andreas Bode, James West, Paul Hayton, James Coop, Christopher Kilbane
  • Patent number: 10561787
    Abstract: A syringe pump includes a lead screw, a motor, and a sliding block assembly. The lead screw has threads and the motor is coupled to the lead screw to rotate it. The half-nut housing has a half nut and a barrel cam. The half nut is disposed within the half-nut housing. The half nut has half-nut threads at an end adjacent to the lead screw void. The half nut engages or disengages with the threads of the lead screw. The half nut includes a half-nut cam-follower surface and a half nut slot. The barrel cam is disposed within the half-nut housing and engages with the half-nut cam-follower surface. The barrel cam includes a pin to fit within the half nut slot such that the barrel cam rotates between a first position and a second position to actuate the half nut between the engagement position and the disengagement position, respectively.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: February 18, 2020
    Assignee: DEKA Products Limited Partnership
    Inventors: Dean Kamen, Larry B. Gray, Jesse T. Bodwell, John M. Kerwin, Dirk A. van der Merwe, Stephen L. Fichera, Jonathan R. Thurber, Martin D. Desch
  • Patent number: 10555871
    Abstract: A cap assembly includes an access member including a first section and a second section. The first section includes a connection portion that is attachable to an extraction device that extracts contents of a reservoir. The connection portion includes a first opening. The second section includes a second opening in fluid communication with the contents of the reservoir when the access member is secured to the reservoir. The cap assembly includes a valve member insertable into the access member so as to be in fluid communication with the first opening and the second opening and such that the valve member i) seals the contents of the reservoir at the first opening when the connection portion is not attached the extraction device, and ii) provides access to the contents of the reservoir through the first opening when the connection portion is attached to the extraction device.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: February 11, 2020
    Assignee: KLIM-LOC, LLC
    Inventor: Robbie Klimek
  • Patent number: 10549051
    Abstract: A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.
    Type: Grant
    Filed: January 15, 2018
    Date of Patent: February 4, 2020
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Patent number: 10549036
    Abstract: A system and method for providing closed loop infusion formulation delivery which accurately calculates a delivery amount based on a sensed biological state by adjusting an algorithm's programmable control parameters. The algorithm calculates a delivery amount having proportional, derivative, and basal rate components. The control parameters may be adjusted in real time to compensate for changes in a sensed biological state that may result from daily events. Safety limits on the delivery amount may be included in the algorithm. The algorithm may be executed by a computing element within a process controller for controlling closed loop infusion formulation delivery. The biological state is sensed by a sensing device which provides a signal to the controller. The controller calculates an infusion formulation delivery amount based on the signal and sends commands to an infusion formulation delivery device which delivers an amount of infusion formulation determined by the commands.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: February 4, 2020
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Timothy J. Starkweather, Ronald J. Lebel, Rajiv Shah, Michael E. Miller
  • Patent number: 10549069
    Abstract: A rapid exchange catheter comprises a guide wire lumen including a substantially sealed portion in which a lumen wall extends around an entire periphery thereof and a channel portion including a channel opening the lumen to an exterior of the catheter, wherein a width of the channel is less than a maximum width of the channel portion. A guide wire ramp extends into the channel portion, with the ramp extending further into the lumen of the channel portion as a distal end of the ramp is approached.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: February 4, 2020
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Michael P. Boutillette, James E. Windheuser, Oscar R. Carrillo, Jr.
  • Patent number: 10549031
    Abstract: Embodiments of the invention provide infusion systems for the intravenous or other delivery of drugs and other therapeutic agents to a patient including a human or mammal. The therapeutic agents may be dissolved in solution or comprise the solution itself. Embodiments of the systems can utilize a chemical reaction to predictably drive a flow of drug(s) through a catheter or other flow path and into the patient. More specifically, the reaction may include an acid-base reaction or any other reaction that produces a gaseous substance. The gas is produced and contained in an expandable drive balloon when the acid-base reactants are combined with a liquid. As the gas is produced, the drive balloon expands to exert pressure on a separately-contained drug reservoir which, in turn, pushes drug(s) from the reservoir into the flow path where the drug is ultimately delivered to the patient in a controlled and predetermined manner.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: February 4, 2020
    Assignee: InCube Labs, LLC
    Inventor: Mir Imran
  • Patent number: 10524957
    Abstract: Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall. The resistance component may be disposed on a removable injector attachment or on a portion of the injection device housing. Other devices may include a filter for the removal of air, infectious agents, and/or other particulate matter from the composition before the composition is injected into the eye. Related methods and systems comprising the devices are also described.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: January 7, 2020
    Assignee: OcuJect, LLC
    Inventor: Leonid E. Lerner
  • Patent number: 10525194
    Abstract: A fluid delivery device comprises a hydraulic pump chamber having a hydraulic fluid. A fluid reservoir is coupled to the hydraulic pump chamber and is configured to contain a fluid deliverable to a patient. A first actuator is coupled to the hydraulic pump chamber and is configured to pressurize the hydraulic pump chamber and configured to transfer energy through the hydraulic pump chamber to the fluid reservoir. A second actuator is coupled to the hydraulic pump chamber and is configured to pressurize the hydraulic pump chamber and configured to transfer energy through the hydraulic pump chamber to the fluid reservoir.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: January 7, 2020
    Assignee: VALERITAS, INC.
    Inventors: Robert R. Gonnelli, Devin V. McAllister, Steven F. Levesque
  • Patent number: 10518041
    Abstract: An Injection device for administering a dose of liquid medicament to patient comprises—a syringe containing the dose of medicament—a hollow injection needle adapted to penetrate skin of the patient,—a stopper translatably disposed within syringe,—a plunger connectable to stopper and translatable in at least a proximal direction to displace stopper in the proximal direction and—a releasable noise component capable of, upon release, generating an audible and/or tactile feedback. The proximal displacement of stopper causes the dose of the medicament to be expelled through the hollow injection needle. The noise component is released when the plunger reaches a position relative to the syringe in which stopper is located in proximity of a proximal end of the syringe. The released noise component impacts on at least one component of the injection device to generate the audible and/or tactile feedback indicating the end of the injection.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: December 31, 2019
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Simon Francis Brereton, Thomas Kemp, Rosie Burnell, Matthew Ekman
  • Patent number: 10518037
    Abstract: An injection device includes a housing having a receptacle for a vessel for holding injection fluid; an operator-manipulated element for setting an injection dose; a dosing member rotatable about a longitudinal center axis relative to the housing when setting the injection dose; a feed part; and, a latching unit acting between the feed part and housing. The dosing member has a zero position whereat no dose is set and an injection position whereat an intended dose of injection fluid is set. A spring acts between the dosing member and the housing to return the dosing member from an intermediate position to the injection position or a zero position.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: December 31, 2019
    Assignee: Haselmeier AG
    Inventors: Joachim Keitel, Daniel MacDonald, Herbert Bechtold
  • Patent number: 10512761
    Abstract: Disclosed is a localized method for treatment of cancer including the steps of providing a drug delivery catheter; navigating the catheter to the bile duct; and delivering a therapeutic agent into the bile duct. According to one aspect of the method, the drug delivery catheter is a multi-occlusion balloon catheter. The multi-occlusion balloon catheter may include at least two balloons. The multi-occlusion balloon catheter may optionally include a pressure transducer between the balloons to optimize delivery technique.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: December 24, 2019
    Assignee: RenovoRx, Inc.
    Inventors: Ramtin Agah, Imtiaz L. Qureshi, Kamran Najmabadi, Shaun R. Bagai
  • Patent number: 10493213
    Abstract: In an elongated casing, an active agent container connected to an injection needle can be shifted axially by a spring force. Auto-injectors which are sold or distributed filled and with the springs tensed have to be provided with a needle protecting cap to ensure the sterility of the injection needle. When such a needle protecting cap is removed as preparation for using the auto-injector, a tensile force can be exerted on the active agent container. Therefore, the active agent container comprising the injection needle must be prevented from being undesirably pulled forwards. At least one latching tongue prevents the active agent container from being prematurely shifted with respect to the casing, by abutting a flange arranged on a sliding sleeve which accommodates the active agent container. When the auto-injector is placed onto a person's skin, a needle protecting tube is shifted into the casing, forcing the latching tongue away from the flange and, thus, freeing the travel path for needle movement.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: December 3, 2019
    Assignee: TecPharma Licensing AG
    Inventors: Edgar Hommann, Benjamin Scherer
  • Patent number: 10485937
    Abstract: Disclosed is a dispensing system. The dispensing system includes a dispensing unit to dispense therapeutic fluid, and a validation mechanism to enable operation of the dispensing unit based, at least in part, on a determination of whether operation of the dispensing device is authorized.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: November 26, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret